← Leaderboards
Roger A Rajewski
University Of Virginia
$1,702,496
Attributed
$5,958,897
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $716.8K · FY2010–23$1M$750K$500K$250K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$5,958,897 · 2
By mechanism
R01$5,958,897 · 2
Top collaborators
- John Hackett Bushweller9 shared
- Lucio H. Castilla9 shared
- Monica L Guzman5 shared
Most similar at University Of Virginia
Same institution · by research overlap
- Lucio H. Castilla$7,520,870
- John Hackett Bushweller$17,127,098
- Monica L Guzman$6,874,300
Others in their field
Top investigators on “Relapse”
- Ralph Parchment · Leidos Biomedical Research, Inc.$141,315,269
- Charles A Coltman · Southwest Oncology Group$124,514,512
- Mary M Horowitz · Medical College Of Wisconsin$85,160,686
- Monica M Bertagnolli · Strang Cancer Prevention Center$41,995,734
- Effie W Petersdorf · Fred Hutchinson Cancer Research Center$29,676,600
- Misty Ward Stevens · Intervexion Therapeutics, Llc$28,867,910
Research focus
RelapsePhenotypeProtein Protein InteractionMouse ModelMutationPharmaceutical PreparationsHematopoiesisGenesMalignant NeoplasmsLiteratureApoptosisCore-Binding FactorOlder PatientPharmaceutical ChemistryDrug KineticsChimeric ProteinsCancer Stem CellChemotherapyCbfb GeneIn VivoCytotoxic ChemotherapyLeukemiaCellsRepression
Grant awards (9)
Targeted Small Molecule Inhibitors for Inv(16) Leukemia$666,852
R01 · FY2023 · CA
Targeted Small Molecule Inhibitors for Inv(16) Leukemia$667,159
R01 · FY2022 · CA
Targeted Small Molecule Inhibitors for Inv(16) Leukemia$678,851
R01 · FY2021 · CA
Targeted Small Molecule Inhibitors for Inv(16) Leukemia$675,954
R01 · FY2020 · CA
Targeted Small Molecule Inhibitors for Inv(16) Leukemia$716,817
R01 · FY2019 · CA
Development of Inhibitors of the Leukemia Fusion Protein CBFbeta-SMMHC$593,059
R01 · FY2013 · CA
Development of Inhibitors of the Leukemia Fusion Protein CBFbeta-SMMHC$630,914
R01 · FY2012 · CA
Development of Inhibitors of the Leukemia Fusion Protein CBFbeta-SMMHC$642,418
R01 · FY2011 · CA
Development of Inhibitors of the Leukemia Fusion Protein CBFbeta-SMMHC$686,873
R01 · FY2010 · CA